CD8A and neoplasm: Moreover, Lee K-H and colleagues showed that oral administration of an active and selective MCSF-1R inhibitor to C57BL/6 mice bearing the MC38 murine colon tumor increased the M1/M2 macrophage ratio and the number of cytotoxic CD8+ T-cells within the tumor, with the downstream effect of delaying the tumor growth (46).